Key points are not available for this paper at this time.
are various plants having scientific evidence of anticancer property. Nowadays, many herbs are under clinical studies and being investigated phytochemically to understand their anticancer potential. More than 25% of drugs used during the last 20 years are directly derived from plants, while the other 25% are chemically altered natural products. Nine plant-derived compounds including vinblastine, vincristine, etoposide, teniposide, taxol, navelbine, taxotere, topotecan and irinotecan have been approved for use as anticancer drugs. 10-hydroxycamptothecin, monocrotaline, d-tetrandrine, lycobetaine, indirubin, colchicinamide, curcumol, curdione, gossypol and homoharringtonine are few more plant-derived compounds of high hope. ch herb contains multiple active principles that often operate synergistically producing therapeutic benefits and lowering the risks of adverse effects; and avoids the need for supplemental therapy to manage cancer cachexia. Now it is important to raise awareness and encourage implementation of Ayurvedic therapies for combating cancer and suggest an integrated approach in tumor management and treatment.
Kosta et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: